Table of Contents
What Is Lifespan Edge?
Lifespan Edge is a next-generation longevity clinic redefining how Americans approach healthy aging. Co-founded by futurist and financial author John Mauldin and preventive medicine pioneer Dr. Michael Roizen, the clinic combines advanced diagnostics, personalized prevention strategies, and cutting-edge research to help individuals live longer, healthier lives.
Moreover, Lifespan Edge operates on a clear mission: empower people with data-driven, physician-led care that goes far beyond traditional checkups. As a result, the clinic attracts high-performance individuals who want to stay ahead of aging—not simply react to it.
New Clinic Locations Across the U.S.
On June 30, 2026, Lifespan Edge announced two major new openings. The first clinic opens in West Palm Beach, Florida, bringing longevity care to one of the country’s fastest-growing health-conscious communities. The second location launches in Columbia, Maryland, extending access to the mid-Atlantic region.
Additionally, the company has confirmed plans for a third premier destination clinic in Scottsdale, Arizona. This strategic expansion signals Lifespan Edge’s commitment to making precision longevity care accessible across key U.S. markets.
Why These Locations Matter
- West Palm Beach, Florida — a hub for health-focused retirees and high-net-worth individuals seeking proactive wellness solutions
- Columbia, Maryland — centrally positioned between Baltimore and Washington, D.C., serving a dense, health-literate professional population
- Scottsdale, Arizona (coming soon) — a premium destination known for wellness tourism and executive health programs
How the Concierge Care Model Works
Each Lifespan Edge clinic delivers a concierge-style, physician-led experience. Unlike traditional primary care, this model builds personalized prevention strategies around comprehensive diagnostics. Physicians take time to understand each patient’s biology, lifestyle, and long-term goals.
Furthermore, the approach integrates the latest longevity science with actionable health planning. Patients receive detailed biomarker analysis, nutrition guidance, performance optimization strategies, and ongoing monitoring. Consequently, members do not simply visit a doctor—they partner with a dedicated medical team invested in their long-term vitality.
Core Services Include:
- Advanced biomarker diagnostics — tracking key health indicators before symptoms appear
- Personalized prevention plans — tailored to each individual’s biology and risk profile
- Performance optimization — supporting cognitive sharpness, physical endurance, and energy levels
- Therapeutic Plasma Exchange (TPE) — a frontier treatment under active clinical investigation
Therapeutic Plasma Exchange and Cognitive Health
One of Lifespan Edge’s most forward-looking offerings involves Therapeutic Plasma Exchange (TPE). This treatment replaces a portion of a patient’s plasma to potentially remove age-related proteins and inflammatory markers that accumulate over time.
Notably, Lifespan Edge cites findings from the AMBAR trial (Alzheimer’s Management By Albumin Replacement), which showed early promise in slowing aspects of cognitive and functional decline in Alzheimer’s patients. The clinic emphasizes these findings while being transparent about the need for further clinical study.
What the Research Shows
- The AMBAR trial results suggest TPE may slow cognitive decline in certain Alzheimer’s patient groups.
- Researchers identified measurable differences in functional decline between treated and control groups.
- Scientists still need larger, long-term studies to confirm TPE’s role in standard longevity care.
Therefore, Lifespan Edge does not position TPE as a cure. Instead, the clinic presents it as a promising, evidence-informed intervention worth serious consideration for appropriate patients.
Building the World’s Largest TPE Database
Beyond clinical care, Lifespan Edge actively pursues research leadership. The company is building what it calls the world’s most comprehensive Therapeutic Plasma Exchange database. This effort aims to aggregate real-world patient data to advance the science of longevity medicine.
As a result, each patient who undergoes TPE at a Lifespan Edge clinic contributes to a growing body of evidence. This data-driven approach supports better treatment decisions over time. It also positions Lifespan Edge as a thought leader in the emerging field of precision longevity science.
About the Founders
John Mauldin — A globally recognized futurist, investor, and author, Mauldin brings strategic vision and a deep understanding of emerging trends to Lifespan Edge. His work frequently explores the intersection of technology, economics, and human longevity.
Dr. Michael Roizen — A board-certified preventive medicine physician and bestselling author, Dr. Roizen is best known for developing the concept of “RealAge” — a measure of biological versus chronological aging. He brings decades of clinical experience and research credibility to the Lifespan Edge model.
Together, they lead a company committed to making preventive, precision healthcare the standard — not the exception.
What This Means for Longevity Care
The expansion of Lifespan Edge reflects a broader shift in American healthcare. Consumers increasingly want proactive, personalized care rather than reactive, symptom-based treatment. Furthermore, advances in diagnostics, genomics, and plasma science now make meaningful longevity interventions possible.
Lifespan Edge sits at this intersection. By opening new clinics in Florida and Maryland, the company brings physician-led, data-driven longevity care to more Americans. Meanwhile, the planned Scottsdale location will extend this reach to the Southwest.
In short, Lifespan Edge is not just opening clinics. The company is building a new category of healthcare — one focused on living better, longer.
